Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
29 Novembro 2023 - 6:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K/A
(Amendment No. 1)
Report of Foreign Private Issuer
Pursuant to Rules 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the month of November 2023
Commission File Number: 001-38836
BIOCERES CROP
SOLUTIONS CORP.
(Translation of registrant’s name into English)
Ocampo 210 bis, Predio CCT, Rosario
Province of Santa Fe, Argentina
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F x
Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXPLANATORY NOTE
This Amendment No.1 (the “Amendment”)
to the Current Report on Form 6-K originally filed by Bioceres Crop Solutions Corp. (the “Company”) with the Securities
and Exchange Commission on November 14, 2023 (the “Original Form 6-K”) is being furnished solely for the purpose
of correcting the unaudited consolidated statement of financial position in the press release relating to the first fiscal quarter 2024
financial and operational results contained in Exhibit 99.1 to the Original Form 6-K. Except as specifically described in this
explanatory note, this Amendment does not amend, modify or update any other disclosures contained in the Original Form 6-K.
Exhibit List
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
BIOCERES CROP SOLUTIONS CORP. |
|
(Registrant) |
|
|
|
Dated: November 29, 2023 |
By: |
/s/ Federico Trucco |
|
Name: |
Federico Trucco |
|
Title: |
Chief Executive Officer |
Exhibit 99.1
Unaudited
Consolidated Statement of Financial Position
(Figures in million of U.S. dollars)
ASSETS |
09/30/2023 |
06/30/2023 |
CURRENT
ASSETS |
|
|
Cash
and cash equivalents |
28.4 |
48.1 |
Other
financial assets |
14.6 |
12.1 |
Trade
receivables |
186.3 |
158.0 |
Other
receivables |
24.9 |
28.8 |
Income
and minimum presumed income taxes recoverable |
2.0 |
9.4 |
Inventories |
138.1 |
140.4 |
Biological
assets |
1.1 |
0.1 |
Total
current assets |
395.4 |
397.1 |
NON-CURRENT
ASSETS |
|
|
Other
financial assets |
0.5 |
0.4 |
Other
receivables |
2.4 |
2.5 |
Income
and minimum presumed income taxes recoverable |
0.0 |
0.0 |
Deferred
tax assets |
8.2 |
7.3 |
Investments
in joint ventures and associates |
40.8 |
39.3 |
Property,
plant and equipment |
69.9 |
67.9 |
Investment
properties |
3.7 |
3.6 |
Intangible
assets |
173.0 |
173.8 |
Goodwill |
112.2 |
112.2 |
Right-of-use
asset |
13.5 |
13.9 |
Total non-current assets
|
424.3 |
420.9 |
Total
assets |
819.7 |
818.1 |
LIABILITIES |
|
|
CURRENT
LIABILITIES |
|
|
Trade
and other payables |
159.1 |
150.8 |
Borrowings |
100.7 |
107.6 |
Employee
benefits and social security |
10.0 |
9.6 |
Deferred
revenue and advances from customers |
32.8 |
24.9 |
Income
tax payable |
0.5 |
0.5 |
Consideration
for acquisition |
4.2 |
1.4 |
Lease
liabilities |
4.3 |
3.9 |
Total
current liabilities |
311.7 |
298.7 |
NON-CURRENT
LIABILITIES |
|
|
Borrowings |
48.8 |
60.7 |
Deferred
revenue and advances from customers |
2.2 |
2.1 |
Joint
ventures and associates |
0.6 |
0.6 |
Deferred
tax liabilities |
34.4 |
35.8 |
Provisions |
0.7 |
0.9 |
Consideration
for acquisitions |
2.5 |
3.6 |
Secured
notes |
76.9 |
75.2 |
Lease
liability |
9.2 |
10.0 |
Total
non-current liabilities |
175.4 |
188.9 |
Total
liabilities |
487.1 |
487.6 |
EQUITY |
|
|
Equity
attributable to owners of the parent |
299.0 |
298.6 |
Non-controlling
interests |
33.7 |
31.9 |
Total
equity |
332.6 |
330.5 |
Total
equity and liabilities |
819.7 |
818.1 |
Bioceres Crop Solutions (NASDAQ:BIOX)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Bioceres Crop Solutions (NASDAQ:BIOX)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024